LSTM leads project to develop HIV/AIDS strategy for Libya

August 04, 2009

Liverpool School of Tropical Medicine (LSTM) is leading a project to provide technical assistance to the Libyan government to finalise the development of a national HIV strategy and programme of support. The project is supported by a €1 million grant from the Delegation of the European Commission to Libya.

Between 2009 and 2010, The International Health Group of LSTM in partnership with Libyan institutions and Harvard University's Biostatistics Department (HUBD), will produce updated and comprehensive information on the current epidemiology of HIV infection in the country in order to produce an effective national HIV strategy.

Libya is faced with the challenge of controlling HIV and the provision of appropriate treatment, care and support to children and adults with HIV and AIDS. The problem of the provision of quality care to HIV infected children is compounded by the need to control a concentrated HIV epidemic affecting mainly persons most at risk for which there is limited epidemiological data. The disease is still the object of stigma and fear and there is little known about the drivers of the epidemic among those most at risk as well as the perception of risk and knowledge of HIV among influential sectors of the community.

A skilled and diverse team will work with Libyan institutions to: LSTM's Professor Joseph Valadez will manage the project. He is one of the pioneers of methods to rapidly assess Knowledge, Attitudes and Practices (KAP), having utilised them within HIV assessment programmes throughout the world. The KAP studies will be designed to gather knowledge and misconceptions about HIV transmission and prevention, attitudes associated with stigma and discrimination and high risk behaviours. Surveys will be based on international instruments already field tested but adapted to the Libyan context and will be used to determine how to improve training and capacity building among health facility workers, religious leaders and young people.

Commenting on the programme, Professor Valadez said: "This project will establish an overall HIV strategy for Libya and provide a framework for making important decisions about how to control HIV. It will also aid Libya to join the other countries of North Africa who have HIV strategies and participate in the international UNAIDS community. We hope this project will also allow us all to better understand how HIV is progressing in North Africa and hopefully provide us with information about how to better control it."
-end-


Liverpool School of Tropical Medicine

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.